Table 2–

Pathology and follow-up data

Variable	Results
Patients, n	24
Histology, n (%)
Renal cell carcinoma	23 (95.8)
Papillary type II	1 (4.2)
Tumor grade, n (%)
2	7 (29.2)
3	11 (45.8)
4	6 (25.0)
Stage, n (%)
T3a	5 (20.9)
T3b	14 (58.3)
T3c	2 (8.3)
T4a	3 (12.5)
Positive lymph nodes, n (%)	3 (12.5)
No. of patients with 1-yr Clavien complications, n (%)	4 (16.7)
2	2 (8.3) *
3a	1 (4.2) †
3b	1 (4.2) ‡
Cancer status
Disease free	13 (54.2)
Recurrence	11 (45.8)
Patient status, n (%)
Alive	24 (100)
Dead	0
Adjuvant therapy, n (%)	10 (41.7)
Follow-up, mo, median (range)	16 (12–39)

^*Pulmonary embolism or deep vein thrombosis (treated with nadroparin; occurred within 90 d after surgery).

^†Chylous ascites.

^‡Percutaneous drainage of subphrenic abscess.